Drugs / GSK2654909A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01659086 | Aug → Oct 2012 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK2654909A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01659086 ↗ |
| Modality | Vaccine | “Influenza Vaccines GSK2654911A and GSK2654909A” NCT01659086 ↗ |
| Route | Intramuscular | “All doses to be administered IM in deltoid region of arm.” NCT01659086 ↗ |